Ovarian changes during and after long term steroid contraceptive therapy.
Hefnawi
F
F
Sabry
I
I
Kandil
O F
OF
Wassef
S A
SA
Younis
N
N
D000367:Age Factors; D000463:Algestone Acetophenide; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006653:Histology; D007267:Injections; D008234:Lynestrenol; D008656:Mestranol; D009640:Norethindrone; D010053:Ovary; D010298:Parity; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D013995:Time; D013997:Time Factors; D014566:Urogenital System
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D008656:Mestranol; D008234:Lynestrenol; D000463:Algestone Acetophenide; D009640:Norethindrone
Age Factors; Algestone Acetophenide; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Demographic Factors; Ethinyl Estradiol; Family Planning; Genitalia; Genitalia, Female; Histology; Injectables; Longterm Effects; Lynestrenol; Mestranol; Norethindrone; Norethindrone Acetate; Nulliparity; Oral Contraceptives; Oral Contraceptives, Combined; Ovarian Effects; Ovary; Parity; Physiology; Population; Population Dynamics; Time Factors; Urogenital System